Outcomes and Risks of Granulocyte Colony-Stimulating Factor in Patients With Coronary Artery Disease
- 26 October 2005
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (9), 1643-1648
- https://doi.org/10.1016/j.jacc.2005.01.067
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured ArteriesCirculation, 2004
- Synergistic Effect of Bone Marrow Mobilization and Vascular Endothelial Growth Factor-2 Gene Therapy in Myocardial IschemiaCirculation, 2004
- Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart DiseaseCirculation, 2004
- Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass graftingJournal of the American College of Cardiology, 2003
- Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular RiskNew England Journal of Medicine, 2003
- Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery DiseaseCirculation Research, 2001
- Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase responseExperimental Hematology, 2001
- Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis DrugsCirculation, 2001
- Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)European Journal Of Cancer, 1993